Treace Medical Concepts, Inc.

TMCI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$56-$50-$43-$21
Dep. & Amort.$8$5$2$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$31$17$8$3
Change in WC-$25-$10-$6-$1
Other Non-Cash$5$2$8$0
Operating Cash Flow-$37-$35-$31-$17
Investing Activities
PP&E Inv.-$12-$11-$15-$3
Net Acquisitions$0-$20$62$0
Inv. Purchases-$72-$170-$63$0
Inv. Sales/Matur.$119$120$2$0
Other Inv. Act.$0$0-$62$0
Investing Cash Flow$35-$81-$77-$3
Financing Activities
Debt Repay.$0$0$20-$2
Stock Issued$0$109$2$109
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$1$0
Financing Cash Flow$0$109$21$108
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$6-$86$88
Supplemental Information
Beg. Cash$13$19$106$18
End Cash$11$13$19$106
Free Cash Flow-$49-$46-$45-$20